Diabetes and development of tardive dyskinesia.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 8098587.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Diabetes mellitus has been identified as a possible risk factor for tardive dyskinesia. The authors examined 160 elderly individuals who were beginning neuroleptic treatment; 24 had diabetes and 136 did not. After 43 weeks of neuroleptic exposure, the cumulative incidence rates of tardive dyskinesia were 54.1% (SE = 5.6%) for the diabetics and 25.6% (SE = 16.1%) for the nondiabetics.
Medical subject headings
- Antipsychotic Agents
- Diabetes Complications
- Dyskinesia, Drug-Induced